G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
2.550
+0.020 (0.79%)
Jun 21, 2024, 12:05 PM EDT - Market open

G1 Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2015
Net Income
-47.97-147.56-148.35-99.25-122.45
Upgrade
Depreciation & Amortization
0.510.530.470.580.36
Upgrade
Share-Based Compensation
14.5120.5922.3218.7716.45
Upgrade
Other Operating Activities
-5.39-2.18-6.54-3.846.07
Upgrade
Operating Cash Flow
-38.34-128.62-132.11-83.74-99.57
Upgrade
Capital Expenditures
0-0.5100.15-2.72
Upgrade
Change in Investments
2.81-50.02000
Upgrade
Investing Cash Flow
2.81-50.5300.15-2.72
Upgrade
Share Issuance / Repurchase
0.0652.5492.272.312.71
Upgrade
Debt Issued / Paid
-26.69053.6419.380
Upgrade
Other Financing Activities
-0.28-0.04-0.05--
Upgrade
Financing Cash Flow
-26.9152.5145.8621.692.71
Upgrade
Net Cash Flow
-62.44-126.6513.76-61.9-99.58
Upgrade
Free Cash Flow
-38.34-129.13-132.11-83.59-102.29
Upgrade
Free Cash Flow Margin
-46.46%-251.70%-419.71%-184.59%-
Upgrade
Free Cash Flow Per Share
-0.74-2.96-3.15-2.21-2.73
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).